ALBERT J. PAVUCEK, JR., MBA

Collegeville, PA ****6

484-***-**** (Cell)

Email: acf8er@r.postjobfree.com

EXECUTIVE MANAGEMENT/FINANCE

. Public company CFO with experience with equity offerings, debt

facilities, Board of Directors, investor relations, including

shareholders, Wall Street analysts, investment banks, investor

presentations and road shows.

. Fellow Alumni, the Wharton School, University of Pennsylvania.

. As one of the original members of a start-up commercial organization,

successfully lead the finance and operations groups, building all key

processes, and managed to exceed all financial and operating targets.

. Successful CFO and contract negotiation skills, realizing significant

positive financial and operational results, and increased shareholder

value.

PROFESSIONAL EXPERIENCE

PUBLICIS TOUCHPOINT SOLUTIONS, INC., Yardley, PA 2009-Present

A $400+ million division of the Publicis Groupe SA, is one of the largest

healthcare communications groups in the world. Services include healthcare

sales and marketing solutions.

Chief Financial Officer (2009-Present)

. Consolidated and aligned several stand alone divisions under one cohesive

leadership team and company.

. Helped significantly increase Company's operating results ranging between

+80% and +500%, over the past four years; exceeded all financial and

operating targets for three consecutive years.

. Conduct M&A activities, divestitures, and corporate restructuring to

increase operating results and shareholder value; key driver of contracts

and profit sharing agreements.

. Responsible for all areas of Finance, Information Technology, &

Operations for the Company, consisting of 7 business units. Direct

organization's overall financial policies, overseeing accounting,

finance, budget, credit, SOX, IFRS, and insurance.

ORTHOVITA, INC., Malvern, PA 2006-2009

A $350 million public medical device company that manufactured, developed,

and commercialized spine and orthopedic biomaterials and biologic products.

Chief Financial Officer (2006-2009)

. Key executive that set Company business strategy and value creation.

. Helped significantly increase Company's operating results for three

continuous years, contributing to increased market cap by approximately

$125 million.

. Successfully recapitalized Company with execution of $78 million equity

offering and debt facility, including royalty obligation buy-outs,

without using an investment banker, in July 2007.

. Completed a $28 million public stock offering with UBS Securities in Nov.

2006.

ALBERT J. PAVUCEK, JR. Page Two

. Primary contact with the Wall Street investment community, attracting

simultaneous coverage by 13 sell-side analysts from brokerage firms.

. Hired to rebuild a new Finance and Information Technology organization to

support the growing needs of the company and to remediate several

material weaknesses and significant deficiencies. Resulted in

unqualified audit opinions

for the past three fiscal years, while reducing annual costs in excess of

$1 million, and improving service levels.

PDI, INC., Saddle River, NJ 2001-2006

A $400 million public pharmaceutical commercialization partner.

Senior Vice President, Finance & Operations (2002-2006)

Divisional Chief Financial Officer, Finance Dept. (2001-2002)

. Helped increase business units profitability three fold, year over year,

contributing to increased market cap by approximately $150 million.

. Responsible for all financial projections/forecasting and monthly

analysis of results of operations, including preparation and

review of 10-Qs and 10-K.

. Responsible for all areas of Finance & Operations for the Company,

consisting

of 7 divisions and 3 segments.

Directed organization's overall financial policies, overseeing

accounting, finance, budget, credit, SOX, insurance, tax, and treasury.

. Oversaw operational areas including supply chain management, managed

markets & trade, and operations.

. Performed thorough evaluations of potential investment opportunities for

Company's assets and completed acquisitions. Led acquisition, licensing,

and integration processes, realizing significant value.

. Responsible for all areas of Finance & Operations for the Pharmaceutical

Products Group, a new division of PDI with product sales of over $500

million.

ASTRAZENECA, L.P., Wilmington, DE 1994-2001

$18 billion international pharmaceutical company created in 1999 by the

merger of Astra AB and Zeneca Group PLC.

Sales Force Controller, Finance Department (1996-2001)

Manager, Financial Planning & Analysis (1994-1996)

. Provided financial advice and counsel to senior sales force management,

strategic alliances, and headquarters operations with US sales of $10+

billion and operating budget of $2.0 billion.

. Supported all financial/operational planning, forecasting, and budgeting

of sales force; instrumental in managing total year expenses to within 1%

of forecast for three consecutive years.

. Developed/implemented US synergy targets for sales force and total

company to increase to shareholder value after merger between Astra

Pharmaceuticals, L.P., and Zeneca Inc.

. Major contributor to important projects including several company

expansions, contract sales force expansion, development of strategic

alliance contracts, merger/integration efforts, and strategic plans.

. Implemented new standard financial reporting packages that are still used

by the company.

ALBERT J. PAVUCEK, JR. Page Three

WEST PHARMACEUTICAL SERVICES, INC., Lionville, PA 1990-1994

NYSE listed $500 million international pharmaceutical packaging company.

Finance Manager, Planning and Analysis (1992-1994)

International Financial Analyst, International Division (1990-1992)

. Prepared the consolidation of the $140 million International Division's

financial statements for twenty foreign subsidiaries and two affiliates.

. Implemented new standard financial reporting package for all twenty

subsidiaries that resulted in uniform financial reporting worldwide.

BETZ LABORATORIES, INC., Trevose, PA 1987-1989

NYSE listed $600 million international specialty chemical company.

Cost Accounting Manager, Finance Department

. Implemented standard cost system for new division and established direct

labor/overhead rates.

E.I. DU PONT DE NEMOURS & CO., INC., Wilmington, DE 1984-1987

Premier $30 billion international chemical and oil company.

Financial Accountant, Auditor, Textile Fibers Department

. Compiled/reported departmental company earnings and cash flow statement

for $6 billion division.

. Implemented a new automated cash flow reporting system that resulted in

more accurate/timely data.

EDUCATION

University of Pennsylvania, Wharton School of Business, Philadelphia, PA

Fellow Alumni, the Wharton School, University of Pennsylvania, 2003 -

2005

Temple University, Fox School of Business, Philadelphia, PA

Master of Business Administration, 1990

Major: Finance, GPA 3.5/4.0

Temple University, Philadelphia, PA

Bachelor of Business Administration, 1984

Major: Accounting, GPA 3.8/4.0

President's Scholar, Summa cum Laude, Scholarship Awarded

PROFESSIONAL DEVELOPMEMT

. Completed the University of Pennsylvania's Wharton School's executive

education program "The CFO as a Strategic Business Partner Executive".

Contact this candidate